Item

Quantitative CT measurement of abdominal aortic calcium as a novel prognostic biomarker for non-cancer mortality: post-hoc analysis of the STAMPEDE docetaxel and abiraterone acetate plus prednisone phase 3 trials

El-Taji, O.
; 
McSweeney, D.
; 
Jones, C.
; 
Hoyle, A.
; 
Brown, M.
; 
Pickhardt, P.
; 
Garrett, J.
; 
Motwani, M.
; 
Parmar, M.
; 
Attard, G.
... show 4 more
Citations
Altmetric:
Abstract
Authors
El-Taji, O.
McSweeney, D.
Jones, C.
Hoyle, A.
Brown, M.
Pickhardt, P.
Garrett, J.
Motwani, M.
Parmar, M.
Attard, G.
James, N.
Brown, L.
Sachdeva, A.
Clarke, N.
Affiliation
Univ Manchester, Div Canc Sci, Genito Urinary Canc Res Grp, Manchester, England Univ Manchester, Radiotherapy Related Res Dept, Div Canc Sci, Manchester, Lancs, England Salford Royal NHS Fdn Trust, Dept Urol, Salford, England Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Madison, WI USA Manchester Univ NHS Fdn Trust, Dept Cardiol, Manchester, England Univ Coll London UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit UCL, London, England UCL, Canc Inst, London, England Inst Canc Res, Dept Prostate & Bladder Canc Res, London, England
Description
Date
2025
Publisher
Collections
All Paterson Institute for Cancer Research
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
El-Taji O, McSweeney D, Jones C, Hoyle A, Brown M, Pickhardt P, et al. Quantitative CT measurement of abdominal aortic calcium as a novel prognostic biomarker for non-cancer mortality: Post-hoc analysis of the STAMPEDE docetaxel and abiraterone acetate plus prednisone phase 3 trials. EUROPEAN UROLOGY. 2025 MAR;87. PubMed PMID: WOS:001578717000179. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/628032
Embedded videos